Jul 8, 2024 | Featured, Maryland, News, Science
Bookmark (0) Please login to bookmarkClose Username or Email Address Password Remember Me Genentech is re-introducing Susvimo™, its port delivery system (PDS) for the treatment of wet age-related macular degeneration (AMD). The PDS, a refillable capsule the size of a...
Jun 13, 2024 | Featured, Maryland, News, Science
Bookmark (0) Please login to bookmarkClose Username or Email Address Password Remember Me Beacon Therapeutics, an ophthalmic gene therapy company, has dosed the first patient in its Phase 2/3 VISTA clinical trial for AGTC-501, an emerging gene therapy for X-linked...
Jun 5, 2024 | Featured, Maryland, News, Science
Bookmark (0) Please login to bookmarkClose Username or Email Address Password Remember Me Disulfiram (aka, Antabuse), a drug approved by the US Food & Drug Administration (FDA) for deterring alcohol consumption, has moved into a clinical trial for potentially...
May 22, 2024 | Featured, Maryland, News, Science
Bookmark (0) Please login to bookmarkClose Username or Email Address Password Remember Me InGel Therapeutic’s emerging, innovative cellular treatment for preserving cone-mediated vision in people with retinitis pigmentosa (RP), Usher syndrome, and potentially other...
May 16, 2024 | Featured, Maryland, News, Science
Bookmark (0) Please login to bookmarkClose Username or Email Address Password Remember Me PYC Therapeutics, an Australia-based developer of RNA therapies, reported initial results from its Phase 1 PLATYPUS clinical trial in the US for an RNA therapy known as VP-001...
May 14, 2024 | Featured, Maryland, News, Science
Bookmark (0) Please login to bookmarkClose Username or Email Address Password Remember Me A team of genetic researchers from the UK, US, and Switzerland has identified a mutation in the gene TMEM216 as a common cause of retinitis pigmentosa (RP) in people with African...
